FDA Approves Newly Formulated OTC Primatene Mist (epinephrine) to Treat Mild Asthma

Article Link: FDA Approves Newly Formulated OTC Primatene Mist (epinephrine) to Treat Mild Asthma

RANCHO CUCAMONGA, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) — Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) announced today that the U.S. Food and Drug Administration (FDA) granted approval of its New Drug Application (NDA) for Primatene Mist…

Source: FDA New Drug Approvals